Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 4 (2007), Issue 6 (June)

1. Bioidentical hormones for menopausal hormone therapy: variation on a theme.
   J Gen Intern Med, 22(7): 1030-4. [Abstract] [Full-text]
2. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.
   J Clin Endocrinol Metab, 92(6): 2074-9. [Abstract] [Full-text]
3. Effects of testosterone treatment on endometrial proliferation in postmenopausal women.
   J Clin Endocrinol Metab, 92(6): 2169-75. [Abstract] [Full-text]
4. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.
   Endocr Rev, 28(4): 387-439. [Abstract] [Full-text]
5. A simulation using data from a primary care practice database closely replicated the women's health initiative trial.
   J Clin Epidemiol, 60(7): 686-95. [Abstract] [Full-text]
6. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
   Maturitas, 57(3): 315-24. [Abstract] [Full-text]
7. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
   Maturitas, 57(3): 226-32. [Abstract] [Full-text]
8. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
   Maturitas, 57(3): 239-46. [Abstract] [Full-text]
9. Estrogen therapy and coronary-artery calcification.
   N Engl J Med, 356(25): 2591-602. [Abstract] [Full-text]
10. Sex hormones and the cardiovascular system: effects on arterial function in women.
    Clin Exp Pharmacol Physiol, 34(7): 672-6. [Abstract] [Full-text]
11. Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis.
    J Thromb Haemost, 5(6): 1201-8. [Abstract] [Full-text]
12. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer.
    Cancer Causes Control, 18(7): 723-33. [Abstract] [Full-text]
13. Raloxifene, tamoxifen and vascular tone.
    Clin Exp Pharmacol Physiol, 34(8): 809-13. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.